PharmaResources (Shanghai) Co. Ltd. A

Shares of lab animal concept stocks remain active, with Joinn Laboratories hitting the daily upper limit today, marking its third upper limit in five trading days. The company expects attributable net profit for the first half of 2026 to be between 600 million and 900 million yuan, a year-on-year increase of 884.9% to 1,377.4%. The surge in performance is mainly due to rising market prices for lab monkeys combined with natural growth appreciation. According to data from the Chinese Government Procurement Network, the procurement unit price of cynomolgus monkeys rose from 92,000 yuan in May 2025 to 190,000 yuan in June 2026. A research report from Zheshang Securities points out that domestic annual demand for lab monkeys has exceeded 40,000, with a shortfall of nearly 10,000. It is estimated that the supply-demand gap will be at least 15,000 to 20,000 from 2026 to 2028, and monkey prices may remain elevated.